Application of two neurophysiological tests to identify individual characteristics of patients suffering from borderline personality disorder with and without comorbid post-traumatic stress disorder

• Conditions: F60.3; F43.1; Emotionally unstable personality disorder; Post-traumatic stress disorder

• Registration Number: DRKS00019851
• Lead Sponsor: Zentralinstitut für Seelische Gesundheit

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-11-21
• Study Completion: 2023-02-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 28

Inclusion Criteria

Patients suffering from borderline personality disorder and/or
- posttraumatic stress disorder
-German-speaking
-Capacity to provide informed consent
-Written Informed Consent
-negative breath analysis for alcohol

Exclusion Criteria

- comorbid substance use disorder
- non German-speaking
- lack of capacity to provide informed consent
- lack of written informed consent
- blindness
-neurological deficits influencing the eye-tracking - e.g. no smell or taste

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The aim of the study is to identify clinical phenotypes and parameters to deepen the biological underpinnings of borderline disorder (focusing the opioidergic and dopaminergic system) as well as to predict treatment response to naltrexone in borderline disorder with and without comorbid posttraumatic disorder

Secondary Outcome Measures

Name	Time	Method
not available